NCT03549273 2024-02-07
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Phase 2 Unknown
Clinical Trials
8 trialsNCT04073082 2019-08-30
Safety and Efficacy of Laser Therapy in Gynaecology
Juna d.o.o.
Unknown
NCT02576561 2017-10-25
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
THEVAX Genetics Vaccine
Phase 2 Unknown
NCT02100085 2017-07-12
Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation
Genexine, Inc.
Unknown
NCT02411019 2017-07-12
GX-188E
Genexine, Inc.
Unknown
NCT02596243 2017-07-12
Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)
Genexine, Inc.
Phase 2 Unknown
NCT01880411 2013-06-19
Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine
HealthBanks Biotech Co., Ltd.
Phase 1 Unknown
NCT01371695 2011-06-13
Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
Onconix, Inc
Unknown